25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

JNJ (Johnson & Johnson Co DRC) Stock Analysis
Buy, Hold or Sell?

Let's analyze Johnson & Johnson Co DRC together

I guess you are interested in Johnson & Johnson Co DRC. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – Johnson & Johnson Co DRC’s Financial Insights
  • 📈 Technical Analysis (TA) – Johnson & Johnson Co DRC’s Price Targets

I'm going to help you getting a better view of Johnson & Johnson Co DRC. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Johnson & Johnson Co DRC

I send you an email if I find something interesting about Johnson & Johnson Co DRC.

1. Quick Overview

1.1. Quick analysis of Johnson & Johnson Co DRC (30 sec.)










1.2. What can you expect buying and holding a share of Johnson & Johnson Co DRC? (30 sec.)

How much money do you get?

How much money do you get?
ARS0.97
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
ARS7,921.01
Expected worth in 1 year
ARS8,741.32
How sure are you?
88.2%

+ What do you gain per year?

Total Gains per Share
ARS2,031.44
Return On Investment
16.4%

For what price can you sell your share?

Current Price per Share
ARS12,375.00
Expected price per share
ARS11,225 - ARS12,675
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Johnson & Johnson Co DRC (5 min.)




Live pricePrice per Share (EOD)
ARS12,375.00
Intrinsic Value Per Share
ARS13,449.97 - ARS15,417.88
Total Value Per Share
ARS21,370.99 - ARS23,338.90

2.2. Growth of Johnson & Johnson Co DRC (5 min.)




Is Johnson & Johnson Co DRC growing?

Current yearPrevious yearGrowGrow %
How rich?$76.2b$69.8b$1.1b1.7%

How much money is Johnson & Johnson Co DRC making?

Current yearPrevious yearGrowGrow %
Making money$5.3b$9.3b-$4b-76.4%
Net Profit Margin24.6%45.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Johnson & Johnson Co DRC (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Johnson & Johnson Co DRC?

Welcome investor! Johnson & Johnson Co DRC's management wants to use your money to grow the business. In return you get a share of Johnson & Johnson Co DRC.

First you should know what it really means to hold a share of Johnson & Johnson Co DRC. And how you can make/lose money.

Speculation

The Price per Share of Johnson & Johnson Co DRC is ARS12,375. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Johnson & Johnson Co DRC.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Johnson & Johnson Co DRC, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ARS7,921.01. Based on the TTM, the Book Value Change Per Share is ARS205.08 per quarter. Based on the YOY, the Book Value Change Per Share is ARS-21.52 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ARS302.78 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Johnson & Johnson Co DRC.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 ARS% of Price per ShareARS% of Price per ShareARS% of Price per ShareARS% of Price per ShareARS% of Price per ShareARS% of Price per Share
Usd Eps0.890.0%0.440.0%1.200.0%0.630.0%0.570.0%0.570.0%
Usd Book Value Change Per Share0.540.0%0.160.0%-0.020.0%0.020.0%0.370.0%0.370.0%
Usd Dividend Per Share0.240.0%0.240.0%0.240.0%0.240.0%0.240.0%0.240.0%
Usd Total Gains Per Share0.780.0%0.410.0%0.220.0%0.260.0%0.610.0%0.610.0%
Usd Price Per Share11.66-10.27-7.16-7.64-6.83-6.83-
Price to Earnings Ratio3.27-7.49-4.05--7.74--4.56--4.56-
Price-to-Total Gains Ratio14.96-37.33-60.29-40.57-31.98-31.98-
Price to Book Ratio1.84-1.74-1.25-1.30-1.16-1.16-
Price-to-Total Gains Ratio14.96-37.33-60.29-40.57-31.98-31.98-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share9.9
Number of shares101
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.240.24
Usd Book Value Change Per Share0.160.37
Usd Total Gains Per Share0.410.61
Gains per Quarter (101 shares)41.0461.41
Gains per Year (101 shares)164.14245.63
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1986615495151236
2196133318190301482
3294199482285452728
4391265646380602974
54893318104757531220
65873989745709041466
7685464113866510541712
8783530130276012051958
9881597146685513552204
10979663163095015062450

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%11.01.00.091.7%16.01.00.094.1%16.01.00.094.1%16.01.00.094.1%
Book Value Change Per Share3.01.00.075.0%7.05.00.058.3%12.05.00.070.6%12.05.00.070.6%12.05.00.070.6%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%17.00.00.0100.0%17.00.00.0100.0%17.00.00.0100.0%
Total Gains per Share4.00.00.0100.0%10.02.00.083.3%15.02.00.088.2%15.02.00.088.2%15.02.00.088.2%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Johnson & Johnson Co DRC compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--671.231205.076+227%-21.524+103%28.733+2236%465.942+44%465.942+44%
Book Value Per Share--7921.0157385.039+7%7261.725+9%7405.912+7%7341.905+8%7341.905+8%
Current Ratio--1.2571.117+13%1.164+8%1.170+7%1.223+3%1.223+3%
Debt To Asset Ratio--0.5970.603-1%0.589+1%0.595+0%0.5970%0.5970%
Debt To Equity Ratio--1.4791.518-3%1.439+3%1.476+0%1.4860%1.4860%
Dividend Per Share--303.114302.784+0%296.547+2%299.809+1%294.064+3%294.064+3%
Enterprise Value--34357447462400.00019605316769856.000+75%-17604039416320.000+151%-16250118908864.000+147%-28184128521351.531+182%-28184128521351.531+182%
Eps--1115.406552.937+102%1504.921-26%793.481+41%715.362+56%715.362+56%
Ev To Sales Ratio--0.3220.181+78%-0.168+152%-0.139+143%-0.245+176%-0.245+176%
Free Cash Flow Per Share--341.244470.896-28%462.276-26%448.020-24%454.226-25%454.226-25%
Free Cash Flow To Equity Per Share--1398.136641.873+118%-80.697+106%235.482+494%194.247+620%194.247+620%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--15417.885----------
Intrinsic Value_10Y_min--13449.971----------
Intrinsic Value_1Y_max--1758.757----------
Intrinsic Value_1Y_min--1727.652----------
Intrinsic Value_3Y_max--5121.433----------
Intrinsic Value_3Y_min--4892.632----------
Intrinsic Value_5Y_max--8287.725----------
Intrinsic Value_5Y_min--7706.473----------
Market Cap148876206336000.000-18%175343087462400.000154371091769856.000+14%107702160583680.000+63%114926416091136.000+53%102746343243354.359+71%102746343243354.359+71%
Net Profit Margin--0.5020.246+104%0.450+12%0.276+82%0.261+93%0.261+93%
Operating Margin----0%0.069-100%0.089-100%0.126-100%0.126-100%
Operating Ratio--1.0481.070-2%1.043+1%1.063-1%1.060-1%1.060-1%
Pb Ratio1.562-18%1.8401.736+6%1.246+48%1.296+42%1.164+58%1.164+58%
Pe Ratio2.774-18%3.2677.493-56%4.047-19%-7.737+337%-4.565+240%-4.565+240%
Price Per Share12375.000-18%14575.00012831.750+14%8952.500+63%9553.000+53%8540.559+71%8540.559+71%
Price To Free Cash Flow Ratio9.066-18%10.6787.150+49%5.499+94%5.585+91%4.980+114%4.980+114%
Price To Total Gains Ratio12.701-18%14.95937.325-60%60.293-75%40.570-63%31.976-53%31.976-53%
Quick Ratio--0.2870.303-5%0.383-25%0.438-34%0.514-44%0.514-44%
Return On Assets--0.0570.029+94%0.057+0%0.035+64%0.033+72%0.033+72%
Return On Equity--0.1410.073+92%0.135+4%0.083+69%0.081+75%0.081+75%
Total Gains Per Share--974.345507.860+92%275.023+254%328.542+197%760.006+28%760.006+28%
Usd Book Value--76234384000.00071075980000.000+7%69889164000.000+9%71276873333.333+7%70660849882.353+8%70660849882.353+8%
Usd Book Value Change Per Share--0.5370.164+227%-0.017+103%0.023+2236%0.373+44%0.373+44%
Usd Book Value Per Share--6.3375.908+7%5.809+9%5.925+7%5.874+8%5.874+8%
Usd Dividend Per Share--0.2420.242+0%0.237+2%0.240+1%0.235+3%0.235+3%
Usd Enterprise Value--27485957969.92015684253415.885+75%-14083231533.056+151%-13000095127.091+147%-22547302817.081+182%-22547302817.081+182%
Usd Eps--0.8920.442+102%1.204-26%0.635+41%0.572+56%0.572+56%
Usd Free Cash Flow--3284240000.0004532056000.000-28%4449096000.000-26%4311886666.667-24%4371618823.529-25%4371618823.529-25%
Usd Free Cash Flow Per Share--0.2730.377-28%0.370-26%0.358-24%0.363-25%0.363-25%
Usd Free Cash Flow To Equity Per Share--1.1190.513+118%-0.065+106%0.188+494%0.155+620%0.155+620%
Usd Market Cap119100965068.800-18%140274469969.920123496873415.885+14%86161728466.944+63%91941132872.909+53%82197074594.684+71%82197074594.684+71%
Usd Price Per Share9.900-18%11.66010.265+14%7.162+63%7.642+53%6.832+71%6.832+71%
Usd Profit--10735024000.0005321640000.000+102%9388144000.000+14%5938146666.667+81%5685888941.176+89%5685888941.176+89%
Usd Revenue--21367568000.00021796764000.000-2%20898112000.000+2%22061016000.000-3%22301198117.647-4%22301198117.647-4%
Usd Total Gains Per Share--0.7790.406+92%0.220+254%0.263+197%0.608+28%0.608+28%
 EOD+4 -4MRQTTM+28 -9YOY+24 -143Y+25 -135Y+27 -1110Y+27 -11

3.3 Fundamental Score

Let's check the fundamental score of Johnson & Johnson Co DRC based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-152.774
Price to Book Ratio (EOD)Between0-11.562
Net Profit Margin (MRQ)Greater than00.502
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.287
Current Ratio (MRQ)Greater than11.257
Debt to Asset Ratio (MRQ)Less than10.597
Debt to Equity Ratio (MRQ)Less than11.479
Return on Equity (MRQ)Greater than0.150.141
Return on Assets (MRQ)Greater than0.050.057
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of Johnson & Johnson Co DRC based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5055.908
Ma 20Greater thanMa 5012,236.250
Ma 50Greater thanMa 10012,139.500
Ma 100Greater thanMa 20012,669.500
OpenGreater thanClose12,200.000
Total3/5 (60.0%)

4. In-depth Analysis

4.1 About Johnson & Johnson Co DRC

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; circulatory restoration products for the treatment of calcified coronary artery and peripheral artery diseases; and neurovascular care that treats hemorrhagic and ischemic stroke. This segment offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Fundamental data was last updated by Penke on 2025-06-28 14:07:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is cheap.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Johnson & Johnson Co DRC earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Johnson & Johnson Co DRC to the Drug Manufacturers - General industry mean.
  • A Net Profit Margin of 50.2% means that $0.50 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Johnson & Johnson Co DRC:

  • The MRQ is 50.2%. The company is making a huge profit. +2
  • The TTM is 24.6%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ50.2%TTM24.6%+25.7%
TTM24.6%YOY45.0%-20.4%
TTM24.6%5Y26.1%-1.5%
5Y26.1%10Y26.1%0.0%
4.3.1.2. Return on Assets

Shows how efficient Johnson & Johnson Co DRC is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Johnson & Johnson Co DRC to the Drug Manufacturers - General industry mean.
  • 5.7% Return on Assets means that Johnson & Johnson Co DRC generated $0.06 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Johnson & Johnson Co DRC:

  • The MRQ is 5.7%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 2.9%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ5.7%TTM2.9%+2.8%
TTM2.9%YOY5.7%-2.7%
TTM2.9%5Y3.3%-0.4%
5Y3.3%10Y3.3%0.0%
4.3.1.3. Return on Equity

Shows how efficient Johnson & Johnson Co DRC is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Johnson & Johnson Co DRC to the Drug Manufacturers - General industry mean.
  • 14.1% Return on Equity means Johnson & Johnson Co DRC generated $0.14 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Johnson & Johnson Co DRC:

  • The MRQ is 14.1%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 7.3%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ14.1%TTM7.3%+6.8%
TTM7.3%YOY13.5%-6.2%
TTM7.3%5Y8.1%-0.7%
5Y8.1%10Y8.1%0.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Johnson & Johnson Co DRC.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Johnson & Johnson Co DRC is operating .

  • Measures how much profit Johnson & Johnson Co DRC makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Johnson & Johnson Co DRC to the Drug Manufacturers - General industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Johnson & Johnson Co DRC:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY6.9%-6.9%
TTM-5Y12.6%-12.6%
5Y12.6%10Y12.6%0.0%
4.3.2.2. Operating Ratio

Measures how efficient Johnson & Johnson Co DRC is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • An Operation Ratio of 1.05 means that the operating costs are $1.05 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Johnson & Johnson Co DRC:

  • The MRQ is 1.048. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.070. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.048TTM1.070-0.021
TTM1.070YOY1.043+0.027
TTM1.0705Y1.060+0.009
5Y1.06010Y1.0600.000
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Johnson & Johnson Co DRC.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Johnson & Johnson Co DRC is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • A Current Ratio of 1.26 means the company has $1.26 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Johnson & Johnson Co DRC:

  • The MRQ is 1.257. The company is just able to pay all its short-term debts.
  • The TTM is 1.117. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.257TTM1.117+0.140
TTM1.117YOY1.164-0.046
TTM1.1175Y1.223-0.106
5Y1.22310Y1.2230.000
4.4.3.2. Quick Ratio

Measures if Johnson & Johnson Co DRC is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Johnson & Johnson Co DRC to the Drug Manufacturers - General industry mean.
  • A Quick Ratio of 0.29 means the company can pay off $0.29 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Johnson & Johnson Co DRC:

  • The MRQ is 0.287. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.303. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.287TTM0.303-0.016
TTM0.303YOY0.383-0.079
TTM0.3035Y0.514-0.211
5Y0.51410Y0.5140.000
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Johnson & Johnson Co DRC.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Johnson & Johnson Co DRC assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Johnson & Johnson Co DRC to Drug Manufacturers - General industry mean.
  • A Debt to Asset Ratio of 0.60 means that Johnson & Johnson Co DRC assets are financed with 59.7% credit (debt) and the remaining percentage (100% - 59.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Johnson & Johnson Co DRC:

  • The MRQ is 0.597. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.603. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.597TTM0.603-0.006
TTM0.603YOY0.589+0.014
TTM0.6035Y0.597+0.006
5Y0.59710Y0.5970.000
4.5.4.2. Debt to Equity Ratio

Measures if Johnson & Johnson Co DRC is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Johnson & Johnson Co DRC to the Drug Manufacturers - General industry mean.
  • A Debt to Equity ratio of 147.9% means that company has $1.48 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Johnson & Johnson Co DRC:

  • The MRQ is 1.479. The company is able to pay all its debts with equity. +1
  • The TTM is 1.518. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ1.479TTM1.518-0.038
TTM1.518YOY1.439+0.078
TTM1.5185Y1.486+0.032
5Y1.48610Y1.4860.000
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Johnson & Johnson Co DRC generates.

  • Above 15 is considered overpriced but always compare Johnson & Johnson Co DRC to the Drug Manufacturers - General industry mean.
  • A PE ratio of 3.27 means the investor is paying $3.27 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Johnson & Johnson Co DRC:

  • The EOD is 2.774. Based on the earnings, the company is cheap. +2
  • The MRQ is 3.267. Based on the earnings, the company is cheap. +2
  • The TTM is 7.493. Based on the earnings, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD2.774MRQ3.267-0.493
MRQ3.267TTM7.493-4.227
TTM7.493YOY4.047+3.447
TTM7.4935Y-4.565+12.058
5Y-4.56510Y-4.5650.000
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Johnson & Johnson Co DRC:

  • The EOD is 9.066. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 10.678. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 7.150. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD9.066MRQ10.678-1.612
MRQ10.678TTM7.150+3.527
TTM7.150YOY5.499+1.651
TTM7.1505Y4.980+2.171
5Y4.98010Y4.9800.000
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Johnson & Johnson Co DRC is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • A PB ratio of 1.84 means the investor is paying $1.84 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Johnson & Johnson Co DRC:

  • The EOD is 1.562. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.840. Based on the equity, the company is underpriced. +1
  • The TTM is 1.736. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.562MRQ1.840-0.278
MRQ1.840TTM1.736+0.104
TTM1.736YOY1.246+0.490
TTM1.7365Y1.164+0.572
5Y1.16410Y1.1640.000
4.6.2. Total Gains per Share

2.4. Latest News of Johnson & Johnson Co DRC

Does Johnson & Johnson Co DRC still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Johnson & Johnson Co DRC to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2025-06-30
19:27
PJM Appoints Deena O'Brien as Senior Director of CommunicationsRead
2025-06-28
11:41
Johnson & Johnson’s (JNJ) IMAAVY Demonstrates Superior gMG ControlRead
2025-06-25
21:08
Johnson & Johnson CAR T Therapy Shows 80% Response in Lymphoma TrialRead
2025-06-24
23:21
J&J (JNJ) Faces $8M Verdict Over Talc Case; Stock Still Gains 4.66% YTDRead
2025-06-21
20:01
Mark Cuban Corrects Elizabeth Warren As She Slams JNJ, PFE For Higher Prices And Zero Taxes On Big Pharma: 'PBMs Corrupt Healthcare'Read
2025-06-21
06:12
JNJ’s Consistent Payout Makes It a Top Pick for Down MarketsRead
2025-06-19
19:25
Johnson & Johnson (NYSE:JNJ) Faces US$8 Million Verdict Over Talcum Powder Cancer CaseRead
2025-06-15
09:15
Investigational combination of first-in-class bispecifics TALVEY® and TECVAYLI® shows deep and durable responses in heavily pretreated multiple myeloma patients with extramedullary diseaseRead
2025-06-14
19:16
Johnson & Johnson (NYSE:JNJ) Unveils Promising CAR T-Cell Therapy for B-Cell LymphomaRead
2025-06-14
03:30
UBS Backs Johnson & Johnson as a Defensive Play in Uncertain TimesRead
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2024-03-312024-06-302024-09-302024-12-312025-03-31
Total Other Income Expense Net -3,376,960,0002,058,140,000-1,318,820,000-1,171,200,000-2,490,020,0002,418,040,000-71,980,0008,860,860,0008,788,880,000



6.2. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets193,671,000
Total Liabilities115,562,000
Total Stockholder Equity78,109,000
 As reported
Total Liabilities 115,562,000
Total Stockholder Equity+ 78,109,000
Total Assets = 193,671,000

Assets

Total Assets193,671,000
Total Current Assets71,551,000
Long-term Assets122,120,000
Total Current Assets
Cash And Cash Equivalents 38,474,000
Short-term Investments 307,000
Net Receivables 16,020,000
Inventory 12,659,000
Other Current Assets 4,091,000
Total Current Assets  (as reported)71,551,000
Total Current Assets  (calculated)71,551,000
+/-0
Long-term Assets
Property Plant Equipment 20,871,000
Goodwill 44,468,000
Intangible Assets 36,755,000
Long-term Assets Other 11,534,000
Long-term Assets  (as reported)122,120,000
Long-term Assets  (calculated)113,628,000
+/- 8,492,000

Liabilities & Shareholders' Equity

Total Current Liabilities56,903,000
Long-term Liabilities58,659,000
Total Stockholder Equity78,109,000
Total Current Liabilities
Short Long Term Debt 13,897,000
Accounts payable 9,545,000
Total Current Liabilities  (as reported)56,903,000
Total Current Liabilities  (calculated)23,442,000
+/- 33,461,000
Long-term Liabilities
Long term Debt 38,355,000
Long-term Liabilities Other 10,435,000
Long-term Liabilities  (as reported)58,659,000
Long-term Liabilities  (calculated)48,790,000
+/- 9,869,000
Total Stockholder Equity
Total Stockholder Equity (as reported)78,109,000
Total Stockholder Equity (calculated)0
+/- 78,109,000
Other
Capital Stock3,120,000
Common Stock Shares Outstanding 2,405,625
Net Debt 13,778,000
Net Invested Capital 130,361,000
Net Working Capital 14,648,000
Property Plant and Equipment Gross 49,884,000



6.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-31
> Total Assets 
172,557,000
176,440,000
179,228,000
182,018,000
178,355,000
177,724,000
175,124,000
187,378,000
195,969,000
191,686,000
166,061,000
167,558,000
171,966,000
181,088,000
178,287,000
180,104,000
193,671,000
193,671,000180,104,000178,287,000181,088,000171,966,000167,558,000166,061,000191,686,000195,969,000187,378,000175,124,000177,724,000178,355,000182,018,000179,228,000176,440,000172,557,000
   > Total Current Assets 
52,533,000
53,769,000
59,889,000
60,979,000
60,424,000
63,847,000
65,236,000
55,294,000
64,388,000
60,567,000
53,703,000
53,495,000
57,002,000
57,817,000
53,249,000
55,893,000
71,551,000
71,551,00055,893,00053,249,00057,817,00057,002,00053,495,00053,703,00060,567,00064,388,00055,294,00065,236,00063,847,00060,424,00060,979,00059,889,00053,769,00052,533,000
       Cash And Cash Equivalents 
12,671,000
14,332,000
17,604,000
14,487,000
10,463,000
10,983,000
11,355,000
14,127,000
19,170,000
21,183,000
19,728,000
21,859,000
25,473,000
24,878,000
19,980,000
24,105,000
38,474,000
38,474,00024,105,00019,980,00024,878,00025,473,00021,859,00019,728,00021,183,00019,170,00014,127,00011,355,00010,983,00010,463,00014,487,00017,604,00014,332,00012,671,000
       Short-term Investments 
11,948,000
10,974,000
13,397,000
17,121,000
19,925,000
21,585,000
22,724,000
9,392,000
5,443,000
7,322,000
3,783,000
1,068,000
745,000
597,000
317,000
417,000
307,000
307,000417,000317,000597,000745,0001,068,0003,783,0007,322,0005,443,0009,392,00022,724,00021,585,00019,925,00017,121,00013,397,00010,974,00011,948,000
       Net Receivables 
14,938,000
14,871,000
14,911,000
15,283,000
15,594,000
16,139,000
15,890,000
16,160,000
16,350,000
16,777,000
14,798,000
14,873,000
14,946,000
15,794,000
16,174,000
14,842,000
16,020,000
16,020,00014,842,00016,174,00015,794,00014,946,00014,873,00014,798,00016,777,00016,350,00016,160,00015,890,00016,139,00015,594,00015,283,00014,911,00014,871,00014,938,000
       Inventory 
9,952,000
10,100,000
10,387,000
10,387,000
10,990,000
11,437,000
11,675,000
12,483,000
12,809,000
12,888,000
11,198,000
11,181,000
11,383,000
12,169,000
12,603,000
12,444,000
12,659,000
12,659,00012,444,00012,603,00012,169,00011,383,00011,181,00011,198,00012,888,00012,809,00012,483,00011,675,00011,437,00010,990,00010,387,00010,387,00010,100,0009,952,000
   > Long-term Assets 
120,024,000
122,671,000
119,339,000
121,039,000
117,931,000
113,877,000
109,888,000
132,084,000
131,581,000
131,119,000
112,358,000
114,063,000
114,964,000
123,271,000
125,038,000
124,211,000
122,120,000
122,120,000124,211,000125,038,000123,271,000114,964,000114,063,000112,358,000131,119,000131,581,000132,084,000109,888,000113,877,000117,931,000121,039,000119,339,000122,671,000120,024,000
       Property Plant Equipment 
0
18,632,000
18,478,000
19,862,000
18,701,000
18,354,000
18,152,000
19,803,000
20,174,000
20,576,000
18,821,000
19,898,000
19,632,000
19,748,000
20,479,000
20,518,000
20,871,000
20,871,00020,518,00020,479,00019,748,00019,632,00019,898,00018,821,00020,576,00020,174,00019,803,00018,152,00018,354,00018,701,00019,862,00018,478,00018,632,0000
       Goodwill 
35,688,000
35,819,000
35,569,000
35,246,000
34,935,000
34,166,000
33,383,000
45,231,000
45,575,000
45,440,000
36,124,000
36,558,000
36,616,000
44,250,000
44,799,000
44,200,000
44,468,000
44,468,00044,200,00044,799,00044,250,00036,616,00036,558,00036,124,00045,440,00045,575,00045,231,00033,383,00034,166,00034,935,00035,246,00035,569,00035,819,00035,688,000
       Intangible Assets 
51,110,000
50,244,000
47,776,000
46,392,000
44,420,000
42,408,000
40,336,000
48,325,000
47,448,000
46,246,000
35,021,000
34,175,000
34,286,000
39,725,000
39,490,000
37,618,000
36,755,000
36,755,00037,618,00039,490,00039,725,00034,286,00034,175,00035,021,00046,246,00047,448,00048,325,00040,336,00042,408,00044,420,00046,392,00047,776,00050,244,00051,110,000
       Long-term Assets Other 
6,538,000
7,172,000
6,870,000
10,216,000
9,939,000
9,435,000
8,625,000
9,602,000
9,567,000
10,078,000
13,133,000
14,153,000
14,125,000
10,544,000
10,921,000
11,414,000
11,534,000
11,534,00011,414,00010,921,00010,544,00014,125,00014,153,00013,133,00010,078,0009,567,0009,602,0008,625,0009,435,0009,939,00010,216,0006,870,0007,172,0006,538,000
> Total Liabilities 
106,723,000
106,860,000
108,956,000
107,995,000
103,646,000
101,367,000
100,525,000
110,574,000
125,100,000
115,277,000
94,833,000
98,784,000
101,946,000
109,550,000
108,129,000
108,614,000
115,562,000
115,562,000108,614,000108,129,000109,550,000101,946,00098,784,00094,833,000115,277,000125,100,000110,574,000100,525,000101,367,000103,646,000107,995,000108,956,000106,860,000106,723,000
   > Total Current Liabilities 
40,932,000
38,721,000
44,561,000
45,226,000
43,390,000
44,821,000
45,543,000
55,802,000
60,373,000
54,170,000
44,370,000
46,282,000
48,725,000
53,933,000
51,759,000
50,321,000
56,903,000
56,903,00050,321,00051,759,00053,933,00048,725,00046,282,00044,370,00054,170,00060,373,00055,802,00045,543,00044,821,00043,390,00045,226,00044,561,00038,721,00040,932,000
       Short Long Term Debt 
3,350,000
3,173,000
3,798,000
3,766,000
4,297,000
4,305,000
4,424,000
12,771,000
17,979,000
11,701,000
3,870,000
3,451,000
8,550,000
9,855,000
4,462,000
5,983,000
13,897,000
13,897,0005,983,0004,462,0009,855,0008,550,0003,451,0003,870,00011,701,00017,979,00012,771,0004,424,0004,305,0004,297,0003,766,0003,798,0003,173,0003,350,000
       Accounts payable 
8,503,000
8,704,000
8,961,000
11,055,000
9,309,000
9,765,000
10,153,000
11,703,000
9,909,000
10,443,000
8,355,000
9,632,000
8,174,000
8,848,000
8,954,000
10,311,000
9,545,000
9,545,00010,311,0008,954,0008,848,0008,174,0009,632,0008,355,00010,443,0009,909,00011,703,00010,153,0009,765,0009,309,00011,055,0008,961,0008,704,0008,503,000
       Other Current Liabilities 
0
1,200,000
2,161,000
1,112,000
1,708,000
1,980,000
1,986,000
2,127,000
0
0
0
0
0
0
0
0
0
0000000002,127,0001,986,0001,980,0001,708,0001,112,0002,161,0001,200,0000
   > Long-term Liabilities 
65,791,000
68,139,000
64,395,000
62,769,000
60,256,000
56,546,000
54,982,000
54,772,000
64,727,000
61,107,000
50,463,000
52,502,000
53,221,000
55,617,000
56,370,000
58,293,000
58,659,000
58,659,00058,293,00056,370,00055,617,00053,221,00052,502,00050,463,00061,107,00064,727,00054,772,00054,982,00056,546,00060,256,00062,769,00064,395,00068,139,00065,791,000
       Long term Debt 
30,263,000
30,310,000
30,130,000
29,985,000
28,851,000
28,292,000
27,603,000
26,888,000
34,928,000
33,901,000
26,051,000
25,881,000
25,082,000
31,636,000
31,289,000
30,651,000
38,355,000
38,355,00030,651,00031,289,00031,636,00025,082,00025,881,00026,051,00033,901,00034,928,00026,888,00027,603,00028,292,00028,851,00029,985,00030,130,00030,310,00030,263,000
       Other Liabilities 
0
37,829,000
34,265,000
31,784,000
31,405,000
28,254,000
27,379,000
26,584,000
0
27,206,000
0
0
0
0
0
0
0
000000027,206,000026,584,00027,379,00028,254,00031,405,00031,784,00034,265,00037,829,0000
       Long-term Liabilities Other 
11,941,000
12,724,000
11,177,000
10,686,000
10,497,000
10,524,000
9,918,000
10,437,000
14,421,000
14,582,000
13,562,000
13,398,000
15,067,000
14,086,000
14,923,000
17,549,000
10,435,000
10,435,00017,549,00014,923,00014,086,00015,067,00013,398,00013,562,00014,582,00014,421,00010,437,0009,918,00010,524,00010,497,00010,686,00011,177,00012,724,00011,941,000
> Total Stockholder Equity
65,834,000
69,580,000
70,272,000
74,023,000
74,709,000
76,357,000
74,599,000
76,804,000
70,869,000
75,149,000
71,228,000
68,774,000
70,020,000
71,538,000
70,158,000
71,490,000
78,109,000
78,109,00071,490,00070,158,00071,538,00070,020,00068,774,00071,228,00075,149,00070,869,00076,804,00074,599,00076,357,00074,709,00074,023,00070,272,00069,580,00065,834,000
   Common Stock
0
3,120,000
3,120,000
3,120,000
3,120,000
3,120,000
3,120,000
3,120,000
0
0
0
0
0
0
0
0
0
0000000003,120,0003,120,0003,120,0003,120,0003,120,0003,120,0003,120,0000
   Retained Earnings 
116,508,000
120,154,000
121,092,000
123,060,000
124,380,000
126,216,000
127,917,000
128,345,000
124,558,000
129,381,000
152,536,000
153,843,000
0
0
0
0
0
00000153,843,000152,536,000129,381,000124,558,000128,345,000127,917,000126,216,000124,380,000123,060,000121,092,000120,154,000116,508,000
   Capital Surplus 00000000000000000
   Treasury Stock00000000000000000
   Other Stockholders Equity 000000000-12,967,000-15,292,000-13,843,000-13,757,000-13,058,000-15,415,000-15,100,0000



6.4. Balance Sheets

Currency in USD. All numbers in thousands.




6.5. Cash Flows

Currency in USD. All numbers in thousands.




6.6. Income Statements

Currency in USD. All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue88,821,000
Cost of Revenue-27,471,000
Gross Profit61,350,00061,350,000
 
Operating Income (+$)
Gross Profit61,350,000
Operating Expense-66,672,000
Operating Income22,149,000-5,322,000
 
Operating Expense (+$)
Research Development17,232,000
Selling General Administrative21,969,000
Selling And Marketing Expenses-
Operating Expense66,672,00039,201,000
 
Net Interest Income (+$)
Interest Income1,332,000
Interest Expense-755,000
Other Finance Cost-0
Net Interest Income577,000
 
Pretax Income (+$)
Operating Income22,149,000
Net Interest Income577,000
Other Non-Operating Income Expenses-
Income Before Tax (EBT)16,687,00028,194,000
EBIT - interestExpense = -755,000
14,066,000
14,821,000
Interest Expense755,000
Earnings Before Interest and Taxes (EBIT)-17,442,000
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax16,687,000
Tax Provision-2,621,000
Net Income From Continuing Ops14,066,00014,066,000
Net Income14,066,000
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-6,045,000-577,000
 

Technical Analysis of Johnson & Johnson Co DRC
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Johnson & Johnson Co DRC. The general trend of Johnson & Johnson Co DRC is BEARISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Johnson & Johnson Co DRC's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-14.3%) Bearish trend (14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Johnson & Johnson Co DRC Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Johnson & Johnson Co DRC.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 12,550 < 12,600 < 12,675.

The bearish price targets are: 11,725 > 11,575 > 11,225.

Know someone who trades $JNJ? Share this with them.👇

Johnson & Johnson Co DRC Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Johnson & Johnson Co DRC. The current mas is .

The long score for the Moving Averages is 6/14.
The longshort score for the Moving Averages is -2/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Johnson & Johnson Co DRC Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Johnson & Johnson Co DRC. The current macd is -4.3117576.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Johnson & Johnson Co DRC price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Johnson & Johnson Co DRC. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Johnson & Johnson Co DRC price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Johnson & Johnson Co DRC Daily Moving Average Convergence/Divergence (MACD) ChartJohnson & Johnson Co DRC Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Johnson & Johnson Co DRC. The current adx is 13.94.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Johnson & Johnson Co DRC shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Johnson & Johnson Co DRC Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Johnson & Johnson Co DRC. The current sar is 11,575.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Johnson & Johnson Co DRC Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Johnson & Johnson Co DRC. The current rsi is 55.91. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Johnson & Johnson Co DRC Daily Relative Strength Index (RSI) ChartJohnson & Johnson Co DRC Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Johnson & Johnson Co DRC. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Johnson & Johnson Co DRC price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Johnson & Johnson Co DRC Daily Stochastic Oscillator ChartJohnson & Johnson Co DRC Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Johnson & Johnson Co DRC. The current cci is 31.07.

Johnson & Johnson Co DRC Daily Commodity Channel Index (CCI) ChartJohnson & Johnson Co DRC Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Johnson & Johnson Co DRC. The current cmo is 22.68.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Johnson & Johnson Co DRC Daily Chande Momentum Oscillator (CMO) ChartJohnson & Johnson Co DRC Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Johnson & Johnson Co DRC. The current willr is -21.95121951.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Johnson & Johnson Co DRC is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Johnson & Johnson Co DRC Daily Williams %R ChartJohnson & Johnson Co DRC Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Johnson & Johnson Co DRC.

Johnson & Johnson Co DRC Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Johnson & Johnson Co DRC. The current atr is 282.90.

Johnson & Johnson Co DRC Daily Average True Range (ATR) ChartJohnson & Johnson Co DRC Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Johnson & Johnson Co DRC. The current obv is 540,591.

Johnson & Johnson Co DRC Daily On-Balance Volume (OBV) ChartJohnson & Johnson Co DRC Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Johnson & Johnson Co DRC. The current mfi is 79.32.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Johnson & Johnson Co DRC Daily Money Flow Index (MFI) ChartJohnson & Johnson Co DRC Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Johnson & Johnson Co DRC.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-01-29WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-01-30BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-01-31STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-03STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-02-04STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-02-05WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-02-07WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-02-11STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-02-13CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-02-14STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-17STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-18RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-19STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-02-21BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-02-24STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-26RSI SHORT ENTRY LONG CLOSE70 crossover to downside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-02-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2025-03-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-19RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-28WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-31MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-04-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-04STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-04-10STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-04-15STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-16ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-21STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-22RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-04-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-29STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-05-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-14MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-15RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-05-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-23STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-30CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-06-02STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-06STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-12STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-13STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-06-19STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-06-27MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-06-30SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.

6.3. Candlestick Patterns

Johnson & Johnson Co DRC Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Johnson & Johnson Co DRC based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5055.908
Ma 20Greater thanMa 5012,236.250
Ma 50Greater thanMa 10012,139.500
Ma 100Greater thanMa 20012,669.500
OpenGreater thanClose12,200.000
Total3/5 (60.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Johnson & Johnson Co DRC with someone you think should read this too:
  • Are you bullish or bearish on Johnson & Johnson Co DRC? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Johnson & Johnson Co DRC? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Johnson & Johnson Co DRC

I send you an email if I find something interesting about Johnson & Johnson Co DRC.


Comments

How you think about this?

Leave a comment

Stay informed about Johnson & Johnson Co DRC.

Receive notifications about Johnson & Johnson Co DRC in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.